Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice
Tae-Il Jeon, … , Jarrod L. Larson, Timothy F. Osborne
Tae-Il Jeon, … , Jarrod L. Larson, Timothy F. Osborne
Published October 9, 2008
Citation Information: J Clin Invest. 2008;118(11):3693-3700. https://doi.org/10.1172/JCI36461.
View: Text | PDF
Research Article Genetics

SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice

  • Text
  • PDF
Abstract

Bitter taste–sensing G protein–coupled receptors (type 2 taste receptors [T2Rs]) are expressed in taste receptor cells of the tongue, where they play an important role in limiting ingestion of bitter-tasting, potentially toxic compounds. T2Rs are also expressed in gut-derived enteroendocrine cells, where they have also been hypothesized to play a role in limiting toxin absorption. In this study, we have shown that T2R gene expression in both cultured mouse enteroendocrine cells and mouse intestine is regulated by the cholesterol-sensitive SREBP-2. In addition, T2R stimulation of cholecystokinin (CCK) secretion was enhanced directly by SREBP-2 in cultured cells and in mice fed chow supplemented with lovastatin and ezetimibe (L/E) to decrease dietary sterol absorption and increase nuclear activity of SREBP-2. Low-cholesterol diets are naturally composed of high amounts of plant matter that is likely to contain dietary toxins, and CCK is known to improve dietary absorption of fats, slow gastric emptying, and decrease food intake. Thus, these studies suggest that SREBP-2 activation of bitter signaling receptors in the intestine may sensitize the gut to a low-fat diet and to potential accompanying food-borne toxins that make it past the initial aversive response in the mouth.

Authors

Tae-Il Jeon, Bing Zhu, Jarrod L. Larson, Timothy F. Osborne

×

Figure 1

Identification of mT2R138 as novel SREBP-2 target gene.

Options: View larger image (or click on image) Download as PowerPoint
Identification of mT2R138 as novel SREBP-2 target gene.
SREBP-2 ChIP-chi...
SREBP-2 ChIP-chip analysis was performed in triplicate using 1.5 kb mouse whole genome promoter arrays from NimbleGen/Roche. (A) Representation of the hybridization of ChIP-enriched DNA to the genomic locus for T2R138 analyzed in the Signal Map software program. The top graph in light blue shows the log2 ratios of hybridization signals for tiled probes for SREBP-2 antibody–enriched ChIP DNA divided by nonenriched input DNA. The middle panel, with green symbols, shows a similar analysis when a control IgG fraction was used as antibody. The T2R138 gene coding sequence is indicated by the dark blue area in the bottom graph. chr6, chromosome 6. (B) Oligonucleotides were designed to amplify the binding region of the T2R138 promoter and used in a gene-specific qPCR to confirm the ChIP-chip result using equal amounts of DNA from the input, SREBP-2 antibody–enriched, or control IgG-enriched samples directly as indicated. Data are mean ± SEM; n = 3 for 3 separate experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts